- Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study2016 | Faculty of Medicine in Pilsen
- Tumor necrosis factor alpha inhibitors or interleukin 17 inhibitors in the treatment of patients with axial spondyloarthritis2019 | First Faculty of Medicine
- Interleukin-6, tumor-nekrotizující-faktor-alfa a jejich solubilní receptory u Bence Jonesovy nefropathie. Možná úloha v patogenezi a význam stanovení pro prognózu renální insuficience.1998 | Faculty of Physical Education and Sport
- Koncentrace matrix metaloproteinázy 7 a tumor nekrotizujícího faktoru alfa v bronchoalveolární tekutině u pacientů s NSCLC2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo2016 | Faculty of Medicine in Pilsen
- Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?2014 | Faculty of Medicine in Pilsen
- Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project2014 | Faculty of Medicine in Pilsen
- Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents2016 | Faculty of Medicine in Pilsen
- Treatment options of juvenila idiopathic arthritis: adalimumb2018 | First Faculty of Medicine
- Monocytic deaktivation and production of tumour necrosis factor alpha ex vivo: prognostic parameters in pacients od ICU2003 | First Faculty of Medicine
- Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 20132016 | Faculty of Medicine in Pilsen
- Topical duodenal and gastric mucosal production of interleukin-1beta, interleukin-6, interleukin-8, tumour necrosis alpha and interleukin-2-soluble receptor in Helicobacter pylori positive and negative patients2004 | Faculty of Medicine in Hradec Králové
- Topical duodenal and gastric mucosal production of interleukin-1beta, interleukin-6, interleukin-8, tumour necrosis alpha and interleukin-2-soluble receptor in Helicobacter pylori positive and negative patients2004 | First Faculty of Medicine
- Pentraxin II. Long pentraxins2001 | First Faculty of Medicine
- The different dynamics of leptin and cortisol during infection and non-infectious stress response2001 | First Faculty of Medicine
- The different dynamics of leptin and cortisol during infection and non-infectious stress response2001 | Faculty of Physical Education and Sport
- Tumor necrosis factor alpha (TNFα) inhibitors in the treatment of severe forms of psoriasis2017 | Third Faculty of Medicine
- The Golimumab2010 | First Faculty of Medicine
- Biologic Therapy of Inflammatory Bowel Disease. Antibody against TNF alfa - Infliximab - in Children2003 | First Faculty of Medicine
- Tasonermin as a part of isolated limb perfusion procedure2011 | First Faculty of Medicine
- Use golimumab in therapy of rheumatoid arthritis and ankylosing spondylitis2015 | First Faculty of Medicine
- Biological therapy of Crohn's disease and ulcerative colitis2008 | First Faculty of Medicine
- Pharmacology of golimumab and its use in treating patients with rheumatoid arthritis2013 | Publication without faculty affiliation
- Adalimumab in rheumatologic diagnoses2018 | First Faculty of Medicine
- Biological treatment of Idiopathic inflammatory bowel diseases2015 | First Faculty of Medicine
- Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what's the link?2016 | Faculty of Medicine in Pilsen
- Co je za posledních pět let nového v gastroenterologii2017 | First Faculty of Medicine
- Biological therapy of inflammatory bowel diseases with adalimumab2019 | First Faculty of Medicine
- A severe case of psoriasis treated with brodalumab after failure of previous biologic therapy - case report2022 | Third Faculty of Medicine
- Secukinumab in treating psoriatic arthritis2017 | First Faculty of Medicine